Literature DB >> 28689703

To the G20: incentivising antibacterial research and development.

Christine Årdal1, Enrico Baraldi2, Francesco Ciabuschi3, Kevin Outterson4, John H Rex5, Laura J V Piddock6, David Findlay7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28689703     DOI： 10.1016/S1473-3099(17)30404-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  10 in total

1.  Antimicrobial resistance prevalence, rates of hospitalization with septicemia and rates of mortality with sepsis in adults in different US states.

Authors:  Edward Goldstein; Derek R MacFadden; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  Int J Antimicrob Agents       Date:  2019-03-06       Impact factor: 5.283

Review 2.  Better living through chemistry: Addressing emerging antibiotic resistance.

Authors:  Nathan P Coussens; Ashley L Molinaro; Kayla J Culbertson; Tyler Peryea; Gergely Zahoránszky-Köhalmi; Matthew D Hall; Dayle A Daines
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-06

3.  Alanine Enhances Aminoglycosides-Induced ROS Production as Revealed by Proteomic Analysis.

Authors:  Jin-Zhou Ye; Yu-Bin Su; Xiang-Min Lin; Shi-Shi Lai; Wan-Xin Li; Farman Ali; Jun Zheng; Bo Peng
Journal:  Front Microbiol       Date:  2018-01-30       Impact factor: 5.640

4.  Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis.

Authors:  Edward Goldstein; Scott W Olesen; Zeynal Karaca; Claudia A Steiner; Cecile Viboud; Marc Lipsitch
Journal:  BMC Public Health       Date:  2019-08-19       Impact factor: 3.295

5.  Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA.

Authors:  Pierpaolo Cacciotto; Andrea Basciu; Francesco Oliva; Giuliano Malloci; Martin Zacharias; Paolo Ruggerone; Attilio V Vargiu
Journal:  Comput Struct Biotechnol J       Date:  2021-12-03       Impact factor: 7.271

Review 6.  Antibiotic Discovery and Resistance: The Chase and the Race.

Authors:  Katia Iskandar; Jayaseelan Murugaiyan; Dalal Hammoudi Halat; Said El Hage; Vindana Chibabhai; Saranya Adukkadukkam; Christine Roques; Laurent Molinier; Pascale Salameh; Maarten Van Dongen
Journal:  Antibiotics (Basel)       Date:  2022-01-30

7.  In-depth resistome analysis by targeted metagenomics.

Authors:  Val F Lanza; Fernando Baquero; José Luís Martínez; Ricardo Ramos-Ruíz; Bruno González-Zorn; Antoine Andremont; Antonio Sánchez-Valenzuela; Stanislav Dusko Ehrlich; Sean Kennedy; Etienne Ruppé; Willem van Schaik; Rob J Willems; Fernando de la Cruz; Teresa M Coque
Journal:  Microbiome       Date:  2018-01-15       Impact factor: 14.650

8.  CRISPR-Cas antimicrobials: Challenges and future prospects.

Authors:  Elizabeth Pursey; David Sünderhauf; William H Gaze; Edze R Westra; Stineke van Houte
Journal:  PLoS Pathog       Date:  2018-06-14       Impact factor: 6.823

9.  CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance.

Authors:  Bilal Aslam; Maria Rasool; Adi Idris; Saima Muzammil; Roman Farooq Alvi; Mohsin Khurshid; Muhammad Hidayat Rasool; Derong Zhang; Zhongren Ma; Zulqarnain Baloch
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-10       Impact factor: 4.887

Review 10.  CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria.

Authors:  Dennise Palacios Araya; Kelli L Palmer; Breck A Duerkop
Journal:  PLoS Pathog       Date:  2021-07-08       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.